Recent studies have found that deletion of CCR7 not only leads to reduced plaque content in mice, but also results in disturbed access of T cells to and from the site of plaque inflammation (55).The ApoE-/- mice lacking CD4+ T cells show reduced atherosclerosis (56). Here, CCR7 is linked to atherosclerosis.